Search and Filter
Results per Page:
When donors go all in, the magic begins
Aldarra Foundation achieved maximum impact at Fred Hutch and beyond by giving boldly, with purpose and on a timeline
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Fred Hutch is one of the only centers in the region offering oral medicine services
Specialized oral care for cancer patients is part of multidisciplinary care
Two Fred Hutch studies identify pancreatic cancer biomarker driving basal disease
Dr. Sita Kugel’s team recently published two papers identifying a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes apart, but reveals a biological mechanism that could lead to new therapies
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
TakePART-NW, an ambitious new precision oncology research program, launches at Fred Hutch
Patients who opt in may help solve the mysteries of cancer and other diseases
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows
Five early-career researchers to each receive $50,000 toward innovative cancer research projects
Women’s Health Initiative: Research that keeps on giving
Three decades in, longstanding ‘team science’ study continues to provide answers to health issues facing older women
Pathways Symposium explores lack of access to cancer screening and care
Annual meeting of community partners, patient advocates and researchers tackle geographical, financial and other persistent barriers
Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo
Fred Hutch laboratory research presented at the American Society of Gene and Cell Therapy’s annual meeting moves a promising approach one step closer to clinical trials
New learning lab opens the door to careers in science
Alexandria Real Estate generously invests in life-changing science experiences
Giving that feels ‘beyond meaningful’
The Steinberg family honors the memory of loved ones by celebrating and supporting a profession that takes caring to another level
New hope for people with colorectal cancer that has spread to the liver
Fred Hutch is the only center in Washington state offering high-dose chemotherapy through hepatic artery infusion
Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science
Award recognizes leadership in HIV vaccine trial development, analysis
Highlights from ONS Congress 2025
Fred Hutch nurses gain insights into new research, clinical practices and advancements
Fred Hutch study finds genetic driver of drug resistance in small cell lung cancer
Researchers use CRISPR-Cas9 gene-editing tool on tumor cells grown in mice to better model how tumors that initially respond to chemotherapy become resistant
Providing patient care — and hope — for 35 years
Whether it’s helping establish new care models, administering treatment or supervising teams, Fred Hutch registered nurse Phuong Tran infuses support and dedication into patient and staff experiences
A chair built together
Collective fundraising effort honors Kyle Thomas Spane, fuels research in colon cancer prevention
A swollen lymph node leads to a diagnosis of throat cancer
Fred Hutch treats a patient’s throat cancer with a multispecialty approach that includes state-of-the-art robotic surgery, proton therapy and kindness everywhere he turned
Rare cancer researchers find promising target in fibrolamellar cancer
Fred Hutch’s TRACER initiative digs into aggressive liver cancer, hosts third rare cancer symposium